Inspire Medical Systems Shares Decline Amid Analyst Downgrades

Inspire Medical Systems shares are trading lower after JPMorgan downgraded its rating to Neutral and cut its price target to $110 from $195. Piper Sandler and RBC also reduced their price targets to $150 and $180, respectively, amidst slower-than-expected U.S. rollout of Inspire V system impacting financial outlook.